This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: 89Bio, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Karla K Kopec: Innovator in Biopharmaceuticals
Introduction
Karla K Kopec is a notable inventor based in West Chester, PA (US). She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative work on peptide conjugates.
Latest Patents
Karla holds a patent for "Mutant FGF-21 peptide pegylated conjugates and uses thereof." This invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate that comprises a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker. The patent also details a method for producing this mutant FGF-21 peptide conjugate, along with a pharmaceutical composition and container that includes the conjugate.
Career Highlights
Karla is currently associated with 89Bio, Inc., where she continues to advance her research and development efforts in the biopharmaceutical sector. Her work is pivotal in exploring new therapeutic avenues for various medical conditions.
Collaborations
Karla collaborates with Patrick Mengyuan Liu, contributing to the innovative environment at 89Bio, Inc. Their partnership exemplifies the collaborative spirit essential for breakthroughs in the biopharmaceutical industry.
Conclusion
Karla K Kopec's contributions to the field of biopharmaceuticals through her patent on mutant FGF-21 peptide conjugates highlight her role as an influential inventor. Her ongoing work promises to impact the development of new therapeutic solutions.